Trump’s anti-pharma talk? No problem, say Rx Value lobbyists

new lobbying partnership aimed at preventing government drug-price intervention is unfazed by President-elect Donald Trump’s anti-pharma salvo from his first press conference on Wednesday.

The President-elect’s comments didn’t surprise Joel White, the president of Horizon Government Affairs and the new head of the Rx Value Campaign, which was formed to oppose government intervention on pharmaceutical pricing in favor of free-market solutions. The coalition’s mission was first reported in Politico earlier Wednesday morning.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.